EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study

David Gordon, Edward T Hellriegel, Heidi Rath Hope, David Burt, Joseph B Monahan

Clinical Pharmacology: Advances and Applications · 2021-06 · Volume 13 · 123-134

DOI: 10.2147/cpaa.s305308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2021-06. Verfasst von David Gordon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Aclaris Therapeutics, Inc., Wayne, PA, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

immunologic diseasespharmacokinetics/pharmacodynamicsprotein kinase inhibitorsrheumatoid arthritisserine-threonine kinases

Autor:innen und Institutionen

  • Research and Development, Aclaris Therapeutics, Inc., Wayne, PA, USA.
  • Research and Development, Aclaris Therapeutics, Inc., and Confluence Discovery Technologies, Inc., St. Louis, MO, USA.

Zitieren

APA

Gordon, D., Hellriegel, E. T., Hope, H. R., Burt, D., & Monahan, J. B. (2021). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study. Clinical Pharmacology: Advances and Applications, Volume 13, 123-134. https://doi.org/10.2147/cpaa.s305308

Vancouver

Gordon D, Hellriegel ET, Hope HR, Burt D, Monahan JB. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study. Clinical Pharmacology: Advances and Applications. 2021;Volume 13:123-134. doi:10.2147/cpaa.s305308

BibTeX
@article{Gordon2021,
  author = {Gordon, David and Hellriegel, Edward T and Hope, Heidi Rath and Burt, David and Monahan, Joseph B},
  title = {Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MK2 Inhibitor ATI-450 in Healthy Subjects: A Placebo-Controlled, Randomized Phase 1 Study},
  journal = {Clinical Pharmacology: Advances and Applications},
  year = {2021},
  volume = {Volume 13},
  pages = {123--134},
  doi = {10.2147/cpaa.s305308}
}
Kostenlos starten →